The family of haem oxygenase enzymes is unique in nature for its role in haem degradation. Haem is cleaved at the ␣-meso position by haem oxygenase with the support of electrons donated by cytochrome P450 reductase, the first products of this reaction being CO, iron and biliverdin. Biliverdin is then converted to bilirubin by biliverdin reductase. If haem is viewed as a substrate for an anabolic pathway, it becomes evident that haem oxygenases do not break down haem for elimination from the body, but rather use haem to generate crucial molecules that can modulate cellular functions. The facts that biliverdin and bilirubin are potent antioxidants and that CO is both a vasoactive and signalling molecule sustain this idea. The existence of a constitutive haem oxygenase (HO-2), mainly present in the vasculature and nervous system, and an inducible haem oxygenase (HO-1), which is highly expressed during stress conditions in all tissues, also suggests that cells have evolved a fine control of this enzymic pathway to ultimately regulate haem consumption and to ensure production of CO, biliverdin/bilirubin and iron during physiological and pathophysiological situations. This review will focus primarily on the biological actions of biliverdin and bilirubin derived from the haem oxygenase/biliverdin reductase systems and their potential roles in counteracting oxidative and nitrosative stress.
Introduction
The progress in the field of haem oxygenase research has established some important facts about this enzymic system and more investigations are now required to reveal the roles of haem oxygenase products in cellular mechanisms of homoeostasis and defence. In fact, numerous studies have shown that induction of HO-1 (haem oxygenase 1) is a prerequisite for protection against a variety of stressful events [1] [2] [3] [4] [5] and the report of the first identified HO-1-deficient human patient has corroborated this notion [6] . However, many legitimate questions originate with regard to CO, biliverdin and bilirubin as well as iron. What are the effects of biliverdin and bilirubin once they are produced intracellularly? Do they really act as endogenous antioxidants and, if so, what are their targets for protection? Iron stimulates up-regulation of ferritin, but iron itself has many regulatory functions that include activation of specific genes. Lately CO has received increasing attention and it appears that antiinflammatory [7] and anti-apoptotic [8] features have been added to the vasoactive [9, 10] , anti-proliferative [11] and potential neural messenger [12] actions elicited by this gaseous molecule. In this respect, we have recently published information about a novel group of substances based on transitionmetal-carbonyl complexes that are capable of carrying and releasing CO in biological systems [13, 14] . These CO-releasing molecules have shown very promising results as they are able to vasodilate pre-contracted aortic vessels and prevent both systemic hypertension and coronary constriction caused by a nitric oxide synthase inhibitor, closely mimicking the effects observed following induction of HO-1 [9, 13] . Since the original CO-releasing molecules identified are only soluble in organic solvents, our research in this direction is now focusing on the synthesis and characterization of water-soluble COreleasing molecules for both research and future therapeutic purposes [15, 16] . The idea of creating molecules that can release CO with different kinetics and, eventually, to targeted tissues is also under intense scrutiny. It is our hope that these newly discovered substances can be a useful research tool for investigating more closely the physiological mechanisms and targets of CO in the organism. Indeed, studies using CO-releasing molecules to assess the role of CO in dilatation of cerebral arterioles [17] and to implicate CO in the antiinflammatory properties of a cyclopentenone prostaglandin in macrophages [18] have already been reported and two comprehensive reviews on the bioactive features of CO-releasing molecules have been recently published by our group [15, 16] .
Although a PubMed search (http://www.ncbi.nlm.nih.gov/entrez/ query.fcgi?db=PubMed) for bilirubin yields several thousands of articles, it is surprising to note that only very few of these publications consider haem oxygenase-derived bilirubin and the physiological importance of this bile pigment in protection from diseases. This is mainly because in the clinical setting bilirubin has always been associated with neonatal jaundice and kernicterus and the fact that hyperbilirubinaemia is an index of liver dysfunction. Therefore, as is the case with CO, there is still a general preconception among the medical and scientific community that bilirubin is toxic and dangerous. Indeed, this is true in many circumstances; for example, irreversible damage to cells and tissues is promoted by bilirubin when present at very high concentrations (approx. 300-400 M in the case of kernicterus). However, these levels of bilirubin are only reached in rare cases, and the regular and continuous production of the bile pigment under normal conditions is likely to have physiological functions, still to be completely investigated and understood. This review will highlight the most recent advances regarding the regulation of bilirubin production via the haem oxygenase pathway and its consequent beneficial effects against various forms of cellular stress.
Haem oxygenases and consumption of haem
One of the questions being asked frequently by scientists who are still skeptical about the importance of the haem oxygenase/CO/bilirubin system is related to the source of haem to be used as a substrate for haem oxygenase activity. There is not a straight and accurate answer to this point and undoubtedly more studies are needed to explore this interesting and important aspect of haem metabolism. Despite the limited information provided by the current literature, we can still make some important considerations based on the knowledge available so far. Three major pools of haem can be identified in mammalian tissues: (i) intracellular haem-containing proteins; (ii) haem derived from haemoglobin present in blood and (iii) de novo synthesis of haem, in which the initial and final steps occur in the mitochondria. All three represent significant sources of haem for haem oxygenase enzymes depending on the tissue/organ being analysed and whether there exist underlying disease states or normal conditions. Haem-containing proteins, abundant in all cell types but especially in the liver (cytochromes) and muscular tissue (myoglobin), are subjected to high turnover and haem oxygenases contribute to this process by catabolizing the haem part of the proteins. This pathway is fundamental for the recycling of iron in the body and haem oxygenase derived-products are very likely to be important for iron conservation and mobilization [6, 19, 20] . In blood, each haemoglobin molecule contains four haem groups that can be displaced and lost when the protein is dimerized and oxidized; although some cell-free haemoglobin is normally present in the vasculature, this event is not predominant in physiological situations, where haemoglobin is sequestered within the red blood cells. Endothelial and smooth muscle cells covering the internal lumen of vessels can therefore utilize haem arising from haemoglobin and this source becomes even greater in pathophysiological states characterized by haemolysis, such as sickle cell disease and malaria.
It is a common view that haem is synthesized endogenously for the maintenance of mitochondrial and other haem-containing proteins of the cell. However, we would like to highlight the very interesting findings of two studies investigating the pathway of haem breakdown published more than 10 years ago. Using freshly isolated rat hepatocytes and a radiolabelled haem precursor, ␦-aminolaevulinic acid, Rodgers and colleagues [21] showed that approx. 8% of newly formed haem is converted rapidly into bilirubin. Increased generation of bilirubin was also observed in hepatocytes from rats treated with CoCl 2 , a known inducer of HO-1 and, notably, this effect was not associated with any change in the production of haem. Similarly, studies by Lincoln et al. [22] conducted in cultured chick and rat hepatocytes provided evidence that 17% of newly synthesized haem is broken down immediately prior to its incorpora- tion into cellular haemoproteins and that this fraction increases to 41% when haem oxygenase is induced. These reports strongly suggest that under normal conditions cells synthesize haem not only for the formation of haem-containing proteins, but also to be used specifically as a substrate for haem oxygenase activity. In other words, a certain amount of haem is produced constantly for the purpose of generating biliverdin/bilirubin, CO and iron. Each tissue, depending on intrinsic metabolic activities and exposure to oxidative challenge, may vary the percentage of newly formed haem promptly catabolized by haem oxygenase and, consequently, the basal requirements of bilirubin and CO. Furthermore, the fact that an augmented production of bilirubin is associated with no changes in haem synthesis also points to the possibility that haem could be used preferentially by haem oxygenase in 'emergency' situations. This would allow for a temporarily increased generation of haem metabolites to combat the stressful events that are threatening cell survival. Interestingly, there are also reports describing an up-regulation of ␦-aminolaevulinic acid synthase, the rate limiting enzyme in haem biosynthesis, following induction of HO-1 [23, 24] ; this effect could be viewed as a compensatory mechanism for the decreased endogenous haem content caused by HO-1 enzymic activity. There could also exist important signalling factors that regulate the availability of haem for haem oxygenase by affecting haem uptake into cells. We are extremely attracted by this hypothesis as we have recently obtained new findings indicating that NO might be one of these potential factors. Based on the notion that NO and NO redox forms induce the expression of HO-1 in many different cell types [2, 5, [25] [26] [27] [28] [29] [30] [31] , we wanted to investigate how NO influences HO-1 induction by haemin. We observed that NO donors act synergistically with haemin to augment endothelial haem oxygenase activity to very high levels [32] . Interestingly, this effect was accompanied by a marked elevation in bilirubin production and, more importantly, by a strong magnification of the cellular haem uptake [32] . These data emphasize a previously unknown role for NO in modulating the incorporation of haem into cellular compartments, consequently affecting the expression of HO-1 and the generation of haem-derived products. Although we did not examine the specific mechanism of this phenomenon, we postulated that formation of nitrosyl-haem adducts following nitrosylation of haem by NO could facilitate the increase in haem influx. This idea is sustained by our additional findings showing that NO-releasing agents lose their ability to induce HO-1 in cardiomyocytes when pre-incubated in medium to allow their complete decomposition; however, the presence of haemin during the pre-incubation period preserves the bioactivity of NO donors to synergistically activate HO-1 when added to cells, implicating a direct interaction between haem and the NO groups in the observed effect [33] .
The availability of substrate for haem oxygenase activity may also be one of the factors controlling the excessive generation of haem metabolites, since prolonged generation of CO and bilirubin could potentially exert deleterious effects due to their accumulation. Therefore, by restricting haem synthesis, the production of haem metabolites could be easily limited or discontinued once normal conditions are re-established. This apparently simplistic theory finds support in the recent discovery of Bach1, a DNA-binding protein that senses the intracellular haem content [34] . It appears that Bach1 provides temporal reversible repression of the HO-1 gene by inhibiting the binding activity of activators: when the levels of haem increase Bach1 is displaced, allowing for upregulation of HO-1. Accordingly, in various organs, including thymus, heart and lung, it was found that HO-1 protein is expressed at much higher levels in bach1-deficient mice than in the wild-type counterpart. It would be of particular interest to determine whether other factors besides haem modulate Bach1 function and to establish whether Bach1 is still a key repressor of HO-1 under different conditions that result in HO-1 induction. Based on the fact that HO-2 and HO-3 (haem oxygenases 2 and 3) possess haem-binding motifs, it is tempting to suggest that the two constitutive enzymes might participate in the processes involved in Bach1 regulation.
BVR (biliverdin reductase): a new focus in the pathway of haem breakdown
BVR acts in concert with haem oxygenase to produce bilirubin, the final product of haem degradation. Some of the molecular properties of the enzyme are well characterized and have been corroborated in the publication of the crystal structure of BVR [35] . Among these are the unique dual-pH/dual-cofactor requirements of the enzyme, which uses NADH in the acidic range (peak activity at approx. pH 6.7), in contrast to NADPH, which is used in the basic range (peak activity at approx. pH 8.7) [36] . Recent in vitro studies by Liu and Ortiz de Montellano [37] suggested that BVR facilitates the release of biliverdin from HO-1 and, indeed, the same group has confirmed the ability of BVR to bind to purified HO-1 [38] . Since biliverdin is a negative-feedback inhibitor of haem oxygenase activity [39] , BVR accelerates the catalytic turnover of haem by promoting product release [37] . The importance of BVR is highlighted by the work of Baranano et al. [40] , who showed that the enzyme is a fundamental component of a redox cycle whereby bilirubin oxidized to biliverdin by H 2 O 2 is rapidly converted back to bilirubin by BVR. This results in a magnified protection of neurons against the oxidative damage mediated by high concentrations of H 2 O 2 . In line with these observations, enhanced neuronal expression of BVR was also reported in response to ischaemic brain injury [41] . Perhaps because it is the rate-limiting step in the pathway of haem breakdown, haem oxygenase has been the most studied protein; however, these new interesting investigations indicate that BVR is endowed with important functions that complement and possibly potentiate the protective actions of the haem oxygenase system. It is noteworthy that human BVR can control its activity by means of reversible autophosphorylation, as it was found that phosphorylation is essential for conversion of biliverdin to bilirubin [42] . One wonders if other proteins, including HO-1 and HO-2, could be phosphorylated by BVR. Intriguingly, experimental evidence indicates that BVR forms a homodimer capable of binding to DNA in regions corresponding to the AP-1 (activator protein 1) sites and that BVR-DNA binding is linked to the activation of the HO-1 gene by oxidative stress [43] . Clearly, BVR is surprising us with unexpected important features and more studies are needed to clarify its multiple roles in the pathway of haem degradation.
Antioxidant characteristics of the biliverdin/bilirubin couple
Biliverdin/bilirubin and oxidative stress The most prominent characteristic of the couple biliverdin/bilirubin is the scavenging of oxygen free radicals. Thanks to an extended system of conjugated double bonds and reactive hydrogen atoms (see Figure 1 ), bilirubin and biliverdin can exert potent antioxidant activities towards H 2 O 2 , peroxyl radical, superoxide and hydroxyl radicals [44, 45] . These features are also maintained in hypoxic conditions and when bilirubin is bound to albumin, the major plasma protein responsible for transport of bilirubin across the body [44, 46] . In our studies using cell cultures and isolated heart preparations we were able to confirm the above in vitro findings. In endothelial, smooth muscle and cardiac cells we observed protection by exogenous and endogenously produced bilirubin against various oxidant-related challenges, including H 2 O 2 and peroxynitrite, a H 2 O 2 -generating system and hypoxia-reoxygenation [25, 28, 47, 48] . An example of the cytoprotective activity of bilirubin against oxidant-mediated injury is shown in Figure 2 . In the isolated heart, increased bilirubin production following treatment of rats with haemin as well as exogenous administration of low nanomolar concentrations of bilirubin were associated with significant reduc- tion in post-ischaemic cardiac dysfunction [49] . Similar observations were obtained in cultured neurons [50] , suggesting that bilirubin elicits the same antioxidative actions in different tissues. From our data it also emerged that haem availability is a determinant factor modulating the cytoprotection afforded by bilirubin. In fact, oxidative damage occurs in cells that, despite displaying high HO-1 levels, produce only little bilirubin because of lack of substrate; however, when haemin is provided to support the continuous generation of the bile pigment (and also the other haem-derived products), cells reacquire their ability to counteract oxidant-mediated injury [47, 48] . Another example of the importance of bilirubin is how this antioxidant molecule downregulates the translocation of P-selectin caused by H 2 O 2 , resulting in inhibition of rolling and adhesion of leucocytes in venules [51] . In addition, bilirubin entirely prevented the increase in lipid peroxidation and the decrease in hepatic glutathione observed in rat liver following oxidative stress caused by menadione bisulphite [52] .
Bilirubin tends to accumulate in the cell membrane where it efficiently captures oxygen free radicals [44] . However, little is known about other targets of protection and what the specific subcellular localization of bilirubin is once it is produced following haem breakdown. In our experiments, we can detect bilirubin in the culture medium of cells shortly after treatment with haemin or other stimuli [32, 47] ; this indicates that bilirubin can be easily exported once produced intracellularly and that the endogenous presence of the bile pigment is only transient. We have to emphasize that the culture medium contains albumin, which has a high affinity for bilirubin and might prevent its influx back into the cell. In rat hearts we could measure bilirubin in the reperfusate buffer, which was recirculated in the isolated organ and also in the heart tissue itself [49] , implying that a fraction of generated bilirubin is excreted whereas another is retained by the tissue. Accordingly, bilirubin has been shown to accumulate in neurons [50, 53] and foam cells of atherosclerotic lesions [54] using antibilirubin antibodies. In the case of foam cells, it was found that bilirubin is localized in the perinuclear region where expression of HO-1 is also detected [54] . It is possible that all organelles surrounded by a membrane may bind bilirubin at certain times during the cellular movements of the bile pigment or that there could also exist preferential targets which might require the antioxidant defence provided by bilirubin more than other organelles. The nucleus, containing crucial genetic material, is a likely candidate, since DNA can be attacked and damaged by free radicals with potentially deadly consequences for the cell. Mitochondria, the major source of energy and oxygen free radicals, would also be a predictable target. In this respect, our findings in the isolated heart preparation revealed that induction of HO-1 by haemin or administration of bilirubin at nanomolar concentrations preserved mitochondrial integrity after ischaemia/reperfusion, in sharp contrast to the mitochondria of non-treated hearts, which appeared swollen with disruption of the cristae structure [49] (see Figure 3 ). However, it should be mentioned that mitochondria have been described as being particularly vulnerable to bilirubin-mediated toxicity, with effects ranging from uncoupling of phosphorylation to reduction of oxygen consumption and release of cytochrome c [55] [56] [57] . It must be emphasized that in those studies the concentrations of bilirubin added directly to isolated mitochondria were always in the supraphysiological range and further investigations are necessary to assess the influence of nanomolar to low-micromolar bilirubin on mitochondrial functions and protection against free radical-induced damage.
Metabolic products of bilirubin oxidation
Bilirubin reacting with oxidizing substances gives rise to different products that have been detected in biological fluids such as urine. The colourless fragments derived from bilirubin oxidation were identified as pyrrole fragments and propentdyopent adducts [58, 59] . Some of these products are present in healthy humans [60] and their increased generation can be monitored in rats exposed to endotoxins [61] . This is a sign that bilirubin is a target of oxidative reactions in the organism and that its potential role in vivo is indeed to buffer excessive free radical production. Although biliverdin could be the initial oxidation product of bilirubin, the above findings suggest that further oxidation of bile pigments occurs, leading to cleavage of the molecules. This is mainly because biliverdin can be further oxidized and it is important to note that the amount of biliverdin formed following oxidation of bilirubin changes according to the type of radical used [45, 46, 62] and whether bilirubin is unbound or complexed to albumin [46] . For example, we and others observed that biliverdin was only a negligible product of the reaction of bilirubin with peroxynitrite and reactive nitrogen species [62, 63] (see below). These interesting in vitro experiments were conducted in the absence of BVR, which should convert the newly formed biliverdin back into bilirubin. However, the cascade of oxidative reactions involving the bile pigments could occur at a higher rate compared with the rate of reduction of biliverdin into bilirubin by BVR, especially if bilirubin is oxidized to biliverdin at sites where BVR has no access. This potential scenario could depend on the severity of the oxidative (or nitrosative) challenge and would break the redox cycle proposed by Baranano et al. [40] , increasing the susceptibility of cells to injury. It is tempting to suggest that the good or mal-function of such mechanisms of protection delineates the borderline between reversibility or irreversibility of cellular damage. There is also the possibility that secondary oxidation products of bilirubin could possess antioxidant activities per se and obviously more studies are needed to assess this hypothesis. It is worth mentioning that derivatives of bilirubin oxidation have been shown to cause vasospasm in vitro and are present in the cerebrospinal fluid of patients with subarachnoid haemorrhage, leading to the suggestion that one or more of the degradation products of biliverdin or bilirubin are involved in the vascular complications associated with haemorrhage [59] .
Nitrosative stress and the biliverdin/bilirubin redox system
Soon after we began to work in the field of haem oxygenase research (October 1992), we developed a special interest in the interrelationship between NO and the HO-1 pathway. This was mainly because we initially observed that NO-releasing agents increased the expression of endothelial haem oxygenase activity and this resulted in cytoprotection against H 2 O 2 -mediated damage [25] . With the evolution of this area of investigation, our concepts on the subject have been elaborated in detailed reviews [2, 5] . Here we will focus on the hypothesis that bilirubin and biliverdin can defend cells and tissues against nitrosative stress. By analogy with oxidative stress, which is associated with excessive production of oxygen-derived free radicals, 'nitrosative stress' is a term proposed by Stamler and his group [64] to describe the cellular threat imposed by increased amounts of NO and NO-related species. In view of the fact that HO-1 is induced by high concentrations of NO and its derivatives [26, 28, 31] and based on the idea that HO-1 is part of the adaptive responses utilized by cells for NO detoxification [2, 5] , we postulated that bilirubin and biliverdin could be involved in this protective system by scavenging NO and/or its redox-activated forms. In this respect, interesting results showed that bilirubin effectively prevents the oxidation of plasma proteins caused by peroxynitrite, a strong oxidant derived from the reaction of NO with superoxide [62] . In our studies [63] we employed NO donors that release different NO-related species and specifically: (i) sodium nitroprusside, an NO ϩ donor that is particularly active towards thiolate groups rather than nitrogen centres; (ii) peroxynitrite (ONOO Ϫ ) and 3-morpholinosydnomine, a generator of ONOO Ϫ via the simultaneous release of NO and superoxide anion; (iii) Angeli's salt, which decomposes to give HNO/NO Ϫ (pK a , 11.4) and nitrite ion [31] ; (iv) the NO releaser DEA-NO (diethylamine NONOate) and (v) S-nitrosothiols such as S-nitrosoglutathione, a releaser of NO by homolysis but a reactive nitrosating agent, and S-nitroso-N-acetylpenicillamine, which releases NO rapidly but is a poor NO ϩ donor. We exposed bilirubin or biliverdin to each of the above compounds and monitored their disappearance both by HPLC and spectrophotometrically. We found that bilirubin and biliverdin reacted with all the NO donors used, except sodium nitroprusside, and these reactions were accompanied by loss of bilirubin and biliverdin [63] . We also observed a direct correlation between the rate of release of the NO species and the loss of bilirubin inasmuch as DEA-NO (t 1/2 =2 min) and Angeli's salt (t 1/2 =2.3 min) quickly consumed bilirubin irrespective of the redox form liberated during the reaction (NO or NO Ϫ , respectively). In addition, we showed that pure NO reacts with bilirubin in anaerobic conditions and, collectively, these new findings confirm the ability of the bile pigments to scavenge NO and its redox-activated forms, pointing to the potential function of bilirubin and biliverdin to counteract the cellular stress induced by nitrosative reactions. We also performed experiments in which the release of NO from DEA-NO in rat plasma was measured with a NO electrode. Interestingly, the NO signal that could be clearly detected in normal plasma upon addition of DEA-NO was completely suppressed when the plasma was supplemented with 50 M bilirubin (R. Foresti and R. Motterlini, unpublished work).
Since the physiological presence of S-nitrosothiols has been extensively documented [65] , we have continued our investigations by examining more closely the reaction of bilirubin with S-nitrosocysteine. In collaboration with Dr Cesare Mancuso at the Catholic University in Rome, Italy, we observed that S-nitrosocysteine is able to decrease the half-life of bilirubin in a concentration-dependent manner. Notably this reaction modifies the absorption spectrum of the bile pigment, which shows a gradual increase at 316 nm. This change indicates that bilirubin could be a target for nitrosation reactions since it resembles the modifications that occurr when molecules such as di-peptides and uric acid are nitrosated [65a] . More studies are now required to fully elucidate in vivo the role of bile pigments in protection against NO-mediated toxicity. However, considering that increased generation of reactive oxygen and nitrogen species appears to play a major role in the pathogenesis of vascular, inflammatory and other diseases, we suggest that the positive and beneficial actions of the biliverdin/bilirubin shuttle system are ascribed not only to its powerful antioxidant activities, but also to its emerging antinitrosative properties.
Other described functions of biliverdin and bilirubin
We and others have focused on investigating the defensive role of bilirubin in conditions where oxidative stress is the main cause of tissue damage [28, 46, 47, [49] [50] [51] . However, there are other actions elicited by biliverdin or bilirubin that may account for their evident cytoprotection (or cytotoxicity), ultimately affecting cellular functions. For example, bilirubin can inhibit protein phosphorylation in a process depending on its antioxidants properties [66] but possibly also because of direct interaction with protein kinases [67] . Bilirubin may also possess immunomodulatory features, as it appears to block the cytotoxic activity of human T-lymphocytes [68] . In addition, bilirubin can serve as a ligand for the aryl hydrocarbon receptor, a ligand-activated transcription factor involved in a wide range of cellular responses [69] . Interestingly, Colpaert et al. [70] have recently shown that both biliverdin and bilirubin strongly enhance the relaxation of porcine gastric fundus circular muscle induced by CO, and biliverdin (but not bilirubin) was shown to inhibit the basal and NO-stimulated activity of soluble guanylate cyclase in vitro [71] . As in the mitochondrial studies mentioned above, these investigations were performed using bile pigments at supra-physiological concentrations, suggesting that such actions of biliverdin and bilirubin are potentially ascribed to pathophysiological rather than physiological situations.
Generation of bile pigments by haem oxygenase 187
An intriguing finding reported by McPhee and co-workers [72] focused on the role of bile pigments in modulating HIV-1 infection. Using molecularshape description algorithms, the authors searched for compounds similar in shape to a potent inhibitor of HIV-1 protease. Among the molecules analysed, biliverdin and bilirubin emerged as potential candidates and indeed, when tested in vitro, they inhibited recombinant HIV-1 protease and significantly reduced viral infectivity [72] . Similarly, an anti-HIV activity of biliverdin was suggested to be due to direct inactivation of virions and inhibition of virus binding to target cells [73] . These observations indicate that the levels of bile pigments could influence the course of HIV infections (and perhaps other viral conditions) and that hyperbilirubinaemic patients, such as those affected by Gilbert's syndrome or liver disease, could be less susceptible to acquiring HIV. Epidemiological studies might help to verify this attractive hypothesis.
HO-1-knockout mice as well as the only human deficient in HO-1 described to date showed accumulation of iron in liver and kidney [6, 19] . These consistent findings strongly suggest that HO-1 is involved in reutilization and intracellular metabolism of iron, underlying the existence of novel mechanisms that might be independent from ferritin, the endogenous iron-sequestering protein, the expression of which increases following HO-1 induction for the purpose of storing iron released from haem breakdown [20, 74] . This idea is supported by reports revealing that iron efflux from cells is augmented by HO-1 transfection and reduced in HO-1-deficient fibroblasts [75] and that an iron ATPase, co-localized with HO-1 to microsomal membranes, is induced by iron in the spleen and other tissues [76] . Whether HO-1-derived products could participate in this process is unknown; however, by virtue of the high affinity of CO for iron it has been proposed that iron-CO complexes could form and be released from cells [20] . Notably, bilirubin was also shown in vitro to form complexes with transition metals [77] , including iron, suggesting the possibility that both CO and bile pigments might be involved in iron mobilization. Theoretically, the endogenous physical interaction of bilirubin, iron and CO cannot be excluded at present.
Role of bilirubin in the prevention or mitigation of cardiovascular dysfunction and other disease states
A few years ago we were having a stimulating scientific discussion with our friend and colleague David Sacerdoti from the University of Padova, Italy. In the late 1980s, Sacerdoti et al. [78] reported the important findings that treatment with tin induces HO-1 and prevents the development of hypertension in spontaneously hypertensive rats. In relation to the interesting link that exists between low plasma bilirubin levels and increased risk of cardiovascular disease [79] [80] [81] , David commented openly: "It's a fact for us hepatologists that patients with liver disease rarely develop cardiovascular problems and, in the vast majority of cases, they can live happily with mild hyperbilirubinaemia". This intriguing statement is supported by recent observations showing that the incidence of ischaemic heart disease is lower in Gilbert's syndrome patients than in the general population [82] , possibly because elevated bili-rubin increases the serum antioxidant capacity, thus limiting the oxidative reactions that are involved in atherogenesis. The protective role of bilirubin has been extended also to cancer. In a 10 year follow-up study it was found that the risk of cancer mortality in a Belgian population decreased with increasing concentrations of serum bilirubin and the authors suggested that measurements of bilirubin levels may contribute to cancer risk estimation [83] . In addition, a case was reported where complete resolution of persistent difficult-to-control asthma was achieved in accordance with augmented serum bilirubin due to acute hepatitis B [84] , and the hypothesis that bilirubin is consumed in vivo as an antioxidant in newborns has been advanced following observations that the rate of rise in serum bilirubin in the first few days of life was significantly lower in infants with illnesses that enhance free radical production [85] . Other interesting findings show that the levels of bilirubin derivatives in the cerebrospinal fluid of Alzheimer's disease patients were significantly higher compared with those of controls, suggesting that the increase of degraded bilirubin metabolites in the Alzheimer's brain may derive from the scavenging reaction against chronic oxidative stress [86] . Since oxidative stress appears to be involved in the aetiology of several chronic diseases and human aging in general, we speculate that mild hyperbilirubinaemia could be associated with increased life span. Furthermore, if bilirubin exerts beneficial actions for physical health, it might also positively affect mental well-being. This notion is supported by one study in which patients with winter depression exhibited lower nocturnal bilirubin levels compared with normal volunteers; notably, treatment with light increased bilirubin and was accompanied by clinical improvement [87] . Such effects would be achievable thanks to the sensitivity of bilirubin to light, its lipophilic capacity to cross the blood-brain barrier and its known circadian rhythm, with gradual nocturnal increases and diurnal decreases, leading some authors to propose that bilirubin could serve as a chronobiological photoreceptor [87] .
Conclusions
Although biliverdin and bilirubin appear to participate significantly in the cytoprotective properties of the haem oxygenase pathway, we believe that CO, bile pigments and iron function in concert and should be viewed as an integrated system of cellular defence. In fact, it is even possible that the haem metabolites might contribute to and enhance the cytoprotective actions of one another. We would also like to emphasize that the perception of bilirubin as a dangerous waste product should only be associated with the accumulation of the bile pigment in very high concentrations, whereas the milder increase in bilirubin levels observed with liver or other diseases is an indication of the body stress response and probably reflects attempts made by the organism to counteract the potential tissue damage. Finally, the evolution in the research of haem oxygenase has been very exciting and fascinating, and we look forward to new discoveries that will shed more light on the regulation and functioning of this important system of protection.
